www.vet-webinar.com uses cookies to offer you the best possible service. Read more

Webinars & e-learning courses All webinars

The Clinical and Pathophysiological Aspects of Feline Lung-Digit Syndrome

The Clinical and Pathophysiological Aspects of Feline Lung-Digit Syndrome
The Clinical and Pathophysiological Aspects of Feline Lung-Digit Syndrome

Feline Oncology can be a challenging discipline and clinicians need to understand the natural history of tumours to understand clinical presentation and management. The lifestyle of cats often presents further challenges as clinical features of disease are recognised at a very advanced stage. Lung - digit syndrome in cats is a syndrome commonly associated with lung cancer. In this webinar we will explore clinical presentation and pathophysiology of this condition and how it can be managed. More broadly we will examine the management of lung cancer in cats and other tumours that are associated with the respiratory system. This includes prognosis and management, including palliation.

Recording from 22 June 2023

Speaker:

David.jpeg

David Argyle

Professor, Vice Principal and Head of College of Medicine and Veterinary Medicine

David Argyle is a graduate of Veterinary Medicine and Surgery from the University of Glasgow. He gained his PhD in Immunology and Oncology from the same Faculty. He has served as a clinical academic veterinary oncologist for the Universities of Glasgow, Wisconsin-Madison and Edinburgh. He is an RCVS and European recognized specialist in veterinary oncology and his major interests are cancer biology and comparative oncology. He has published over 160 papers relating to veterinary oncology and written textbook chapters that have underpinned our understanding of canine and feline cancer biology. In 2011 he was appointed William Dick chair of Veterinary Clinical Studies and Dean of Veterinary Medicine at The Royal (Dick) School of Veterinary Studies. In 2022 he was appointed to be Vice Principal and Head of College of Medicine and Veterinary Medicine at the University of Edinburgh, leading 3000 academic staff and 5 research Institutes. In 2016 he was appointed a Fellow of the Royal College of Veterinary Surgeons and, in the same year, a Fellow of the Royal Society of Edinburgh for meritorious contributions to knowledge. He was appointed a Fellow of the Royal Society for the Arts in 2018. In 2015 he was awarded the Kennel Club International Prize for his work to advance the understanding of canine disease.

Booking information

Duration: 0:40 h
Speaker: David Argyle
from 1
54.90 US$
(inkl. tax)

You might also be interested in

veterinary-gb0489bee6_1920300x200.jpg
Penny Thomas
0:51 h

Supportive Care for Cancer Patients for Nurses
How to provide the best nursing care for patients with cancer 
Details
tumor-grading-and-prognosis-in-veterinary-practice-1.jpeg
Sara Belluco
0:44 h

Tumor grading and prognosis in veterinary practice
Tumors are quite frequent in companion animals, with malignant forms representing 56% of all the tumors in dogs and 80% in cats. Predicting the survival time and treatment response for malignant tumors is necessary to evaluate the best care options for the animal. Histological tumor grading helps veterinarians to define the prognosis, but each tumor has its own grading system with different prognosis, in terms of survival rate, metastatic rate, recurrence incidence. It could be not so easy to get your bearings in the pathologic words of gradings. The goal of this seminar is to be able to correlate the validated prognosis to each tumor grading we will see. We will rapidly review what tumor grading is and how it is evaluated. Then we will spend some time to review some of the most important tumor gradings (mammary tumors, mast cell tumors, melanomas, soft tissue sarcomas) and the correlated and validated prognostic factors. At the end of the seminar you will be able to clearly understand your pathologist’s report based on the grading system, and to use it to give an appropriate prognosis to the owners.
Details
chemotherapy-precautions-and-safety-why-how-and-what-to-do-for-nurses-1.jpeg
Momoko Ito
0:45 h

Chemotherapy Precautions and Safety - Why, How and What to do (for Nurses)
Cancer frequently affects our veterinary patients and in recent years chemotherapy has become more commonly utilised treatment. General practices are increasingly prescribing and administering chemotherapy drugs. Chemotherapy drugs are toxic to cells (cytotoxic) interfering with the normal cell life cycle which results in cell death. Cancer cells are targeted by these drugs however they are not specific for cancer cells and healthy tissue can be affected. Chemotherapy drugs are also carcinogenic, mutagenic, teratogenic and abortifacient. It is important that these drugs are handled safely. Personnel handling of chemotherapeutic drugs have been found to have increased risks of infertility, early pregnancy loss or urinary excretion of these drugs. This webinar will discuss the safety precautions necessary for handling chemotherapy agents and will focus on the recent consensus guidelines produced by the American College of Veterinary Internal Medicine (ACVIM) in January 2018 to raise awareness of risks and how we can reduce the exposure within clinics. If time permits, common side effects (neutropaenia, thorombocytopaenia and gastrointestinal side effects) caused by chemotherapy will be explained as well as precautions for handling such patients.
Details
Back to overview
Webinars & e-learning courses